SG11202008345RA - Fecal matter for prevention or treatment of autoimmune diseases - Google Patents
Fecal matter for prevention or treatment of autoimmune diseasesInfo
- Publication number
- SG11202008345RA SG11202008345RA SG11202008345RA SG11202008345RA SG11202008345RA SG 11202008345R A SG11202008345R A SG 11202008345RA SG 11202008345R A SG11202008345R A SG 11202008345RA SG 11202008345R A SG11202008345R A SG 11202008345RA SG 11202008345R A SG11202008345R A SG 11202008345RA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- treatment
- autoimmune diseases
- fecal matter
- fecal
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 210000003608 fece Anatomy 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2020525 | 2018-03-02 | ||
NL2021365A NL2021365B1 (en) | 2018-07-20 | 2018-07-20 | Fecal matter for prevention or treatment of autoimmune diseases |
NL2021370 | 2018-07-20 | ||
NL2021366 | 2018-07-20 | ||
NL2021369 | 2018-07-20 | ||
NL2021367 | 2018-07-20 | ||
PCT/NL2019/050130 WO2019168401A1 (en) | 2018-03-02 | 2019-03-01 | Fecal matter for prevention or treatment of autoimmune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202008345RA true SG11202008345RA (en) | 2020-09-29 |
Family
ID=66290492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202008345RA SG11202008345RA (en) | 2018-03-02 | 2019-03-01 | Fecal matter for prevention or treatment of autoimmune diseases |
Country Status (12)
Country | Link |
---|---|
US (1) | US11534465B2 (en) |
EP (1) | EP3758721B1 (en) |
JP (1) | JP7175990B2 (en) |
KR (1) | KR20200128126A (en) |
CN (1) | CN111936154A (en) |
AU (1) | AU2019229090A1 (en) |
BR (1) | BR112020016771A2 (en) |
CA (1) | CA3091916A1 (en) |
ES (1) | ES2924041T3 (en) |
RU (1) | RU2020131222A (en) |
SG (1) | SG11202008345RA (en) |
WO (1) | WO2019168401A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL2025022B1 (en) | 2020-02-28 | 2021-10-14 | Acad Medisch Ct | Intervention strategy for prevention or treatment of autoimmune diseases |
AU2021228209A1 (en) * | 2020-02-28 | 2022-08-11 | Stichting Amsterdam UMC | Intervention strategy for prevention or treatment of Diabetes mellitus, autoimmune disease, inflammatory disease or cardiovascular disease |
NL2025021B1 (en) | 2020-02-28 | 2021-10-14 | Univ Wageningen | Intervention strategy for prevention or treatment of autoimmune diseases |
NL2025020B1 (en) | 2020-02-28 | 2021-10-14 | Acad Medisch Ct | Intervention strategy for prevention or treatment of autoimmune diseases |
EP4183403A1 (en) * | 2021-11-19 | 2023-05-24 | Lietuvos Sveikatos Mokslu Universitetas | Modification of fecal microbiota with capsules containing gram-positive bacteria |
CN114196543A (en) * | 2021-11-25 | 2022-03-18 | 天津大学浙江绍兴研究院 | A fecal bacteria cryoprotectant and its application in the preservation of fecal bacteria |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9463174B2 (en) * | 2008-12-19 | 2016-10-11 | Qinghua Wang | Pharmaceutical composition for the treatment of type-1 diabetes |
PH12013500224A1 (en) | 2010-08-04 | 2013-04-08 | Borody Thomas J | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
DK2753187T3 (en) * | 2011-08-30 | 2019-01-28 | Caelus Pharmaceuticals B V | Method of preventing and / or treating insulin resistance |
WO2014075745A1 (en) * | 2012-11-19 | 2014-05-22 | Université Catholique de Louvain | Use of akkermansia for treating metabolic disorders |
WO2016070151A1 (en) * | 2014-10-31 | 2016-05-06 | Whole Biome. Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
FR3045383B1 (en) * | 2015-12-18 | 2019-06-14 | Maat Pharma | PROCESS FOR THE FREEZING OF A FECAL MICROBIOTE SAMPLE |
-
2019
- 2019-03-01 EP EP19719936.7A patent/EP3758721B1/en active Active
- 2019-03-01 US US16/976,055 patent/US11534465B2/en active Active
- 2019-03-01 AU AU2019229090A patent/AU2019229090A1/en not_active Abandoned
- 2019-03-01 KR KR1020207028355A patent/KR20200128126A/en not_active Withdrawn
- 2019-03-01 RU RU2020131222A patent/RU2020131222A/en unknown
- 2019-03-01 BR BR112020016771-1A patent/BR112020016771A2/en not_active Application Discontinuation
- 2019-03-01 CN CN201980016702.XA patent/CN111936154A/en active Pending
- 2019-03-01 CA CA3091916A patent/CA3091916A1/en not_active Abandoned
- 2019-03-01 SG SG11202008345RA patent/SG11202008345RA/en unknown
- 2019-03-01 ES ES19719936T patent/ES2924041T3/en active Active
- 2019-03-01 WO PCT/NL2019/050130 patent/WO2019168401A1/en active Application Filing
- 2019-03-01 JP JP2020544205A patent/JP7175990B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3758721A1 (en) | 2021-01-06 |
JP2021514950A (en) | 2021-06-17 |
US11534465B2 (en) | 2022-12-27 |
CA3091916A1 (en) | 2019-09-06 |
CN111936154A (en) | 2020-11-13 |
BR112020016771A2 (en) | 2020-12-15 |
RU2020131222A (en) | 2022-04-06 |
JP7175990B2 (en) | 2022-11-21 |
KR20200128126A (en) | 2020-11-11 |
ES2924041T3 (en) | 2022-10-04 |
US20210137994A1 (en) | 2021-05-13 |
AU2019229090A1 (en) | 2020-10-08 |
WO2019168401A1 (en) | 2019-09-06 |
EP3758721B1 (en) | 2022-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202008345RA (en) | Fecal matter for prevention or treatment of autoimmune diseases | |
ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
ZA202006610B (en) | Compositions for the treatment of skin conditions | |
IL279260A (en) | Kdm1a inhibitors for the treatment of disease | |
ZA202007055B (en) | Compositions for the treatment of skin conditions | |
GB201804514D0 (en) | Treatment of pyroptosis | |
ZA202108219B (en) | Combination treatment of arthritic disease | |
PL3612208T3 (en) | Coversin for the treatment of autoimmune blistering diseases | |
IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
ZA202006234B (en) | Compositions and methods for the treatment of neurological diseases | |
GB201805100D0 (en) | Treatment of sarcopenic diseases | |
ZA201903795B (en) | Treatment of water | |
GB201804515D0 (en) | Treatment of necroptosis | |
IL282360A (en) | Treatment of neurological diseases | |
GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
GB201907305D0 (en) | Treatment of conditions | |
IL261779A (en) | Compositions for the treatment and prevention of hoof and claw diseases | |
GB201806663D0 (en) | 2-Oxothiazole compositions for treatment of fibrotic disease | |
IL278845A (en) | Inhibition of neurological disease | |
PT3752173T (en) | Combination of rhodiola and astragalus for the treatment of neurodegenerative diseases | |
GB201811375D0 (en) | Treatment of autoimmune disease | |
GB2603379B (en) | Avocatin B for the treatment of diseases and conditions | |
GB201811911D0 (en) | Treatment of disease | |
GB201811912D0 (en) | Treatment of disease | |
GB201810974D0 (en) | Treatment of disease |